Jushi Holdings (CSE: JUSH) (OTCQX: JUSHF) - Investor Dashboard

Summary

Financials (09/30/21)

Capital Structure (11/22/21)

Company Brief

Jushi Holdings Inc. (Follow Company) is a vertically integrated multi-state cannabis operator across the United States. The vertically integrated company operates a diverse portfolio of branded cannabis assets, built upon opportunistic acquisitions, distressed deals and competitive applications.

Operating under the Jushi umbrella is the BEYOND / HELLO™  and Nature’s Remedy of Massachusetts, Inc. retail brands of cannabis dispensaries. The Company debuted a comprehensive suite of cannabis brands across multiple states including its award-winning brand, The Lab which offers vape products and concentrates and the award-winning brand, The Bank offering pre-packaged flower and infused blunts. The Company also introduced the following new products: Tasteology for edibles, Nira + Medicinals for THC and CBD-rich medical products, and Sèche for fine flower and pre-rolls to address a wide variety of consumer needs. Jushi strives to maximize shareholder value while delivering high premium products across all levels of the cannabis ecosystem.

June 2021 Investor Update

Highlights

• Raised roughly $400 million since inception
• Approximately $47 million contributed by Founders/Insiders
• Cannabis assets in PA, IL VA, MA, CA, NV, OH; CBD hemp assets in NY
• 24 stores open, 12 stores planned¹, five cultivation facilities and five extraction and processing facilities
• Projecting 2021 revenue of $220 to $230 million, with adjusted EBITDA of $32 to $37 million
• Brand portfolio including The Bank, The Lab, Tasteology, Seche, Nira+ and Nira

1. Includes assets under a Definitive Agreement or an awarded conditional dispensary license where Jushi owns 49% equity

Growth Strategy

• Building a multi-state portfolio of branded cannabis assets through acquisitions, competitive licenses, and expansion within current markets
• Planning to build out its Pennsylvania retail footprint by increasing the Company’s store count to 18 and leveraging its closed acquisition of a Pennsylvania Grower-Processor to supply the market including its own retail stores
• Operating four adult-use stores plus Jushi’s partner was awarded a conditional retail dispensary license in Illinois
• Owning one of five licenses in Virginia with the anticipation of adding five additional BEYOND/HELLO™ branded medical dispensaries to its Dalitso LLC operations near Prince William County, which became operational in December 2020
• Operating two high-performing retail dispensaries, along with a 50,000 square-foot cultivation and production facility in Massachusetts
• Targeting acquisition opportunities in limited licenses jurisdictions to become vertically integrated in markets with high barriers of entry
• Applying for de novo licenses for additional avenues of growth in its existing markets and other key markets
• Plans to increase dispensary count to 36 by the end of 2022
• Increasing its offerings of branded product lines
• Secured $100 million credit facility to fund acquistions

Differentiators

• Integrated, metrics-driven business with seamless integration between online and retail
• Experienced management team with proven track record of allocating and raising capital and identifying distressed assets
• Focused portfolio of assets targeted at high-growth medical (PA,VA, OH) and adult-use markets (IL, NV, CA, MA)
• Solid balance sheet; expansion plans fully funded

Bobby Burleson
Cannacord Genuity

Pablo Zuanic
Cantor Fitzgerald

Kenric Tyghe
ATB Capital Markets

Jason Zandberg, CFA
PI Financial

Andrew Sample
Echelon Capital Markets

Jonathan DeCourcey
Viridian Capital Advisors

Russell Stanley
Beacon Securities

Ty Collin
Eight Capital

Glenn Mattson
Ladenburg Thalmann & Co. Inc